|Articles|December 29, 2021
Pharmacy Clinical Pearl of the Day: Fibroadenoma
Author(s)Saro Arakelians, PharmD
Fibroadenoma may feel like a marble in the breast, moving easily under the skin when examined.
Advertisement
Clinical Pearl of the Day: Fibroadenoma
Fibroadenomas are solid, noncancerous breast lumps that occur most often in women between 15 and 35 years of age.
Insight:
- A fibroadenoma might feel firm, smooth, rubbery or hard, and has a well-defined shape.
- Usually painless, it might feel like a marble in the breast, moving easily under the skin when examined.
- Fibroadenomas vary in size and can enlarge or shrink on their own.
- Fibroadenomas are among the most common noncancerous (benign) breast lumps in young women.
- Symptoms include round with smooth border lumps, which are easily moved, firm, rubbery, and painless.
- Diagnosis may include mammogram, breast ultrasound, and biopsy (fine needles and core needle).
- Types of fibroadenomas may include:
- Complex fibroadenomas, juvenile fibroadenomas, giant fibroadenomas, and phyllodes tumor.
- Treatment may include monitoring to detect changes in size or feel, a biopsy to evaluate the lump, or surgery to remove it.
- Surgery may include lumpectomy or excisional biopsy, or cryoablation.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5